Wells Fargo & Company Cuts Colgate-Palmolive (NYSE:CL) Price Target to $92.00

Colgate-Palmolive (NYSE:CL) had its price target decreased by research analysts at Wells Fargo & Company from $100.00 to $92.00 in a report issued on Monday, Benzinga reports. The firm currently has an “underweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential downside of 4.50% from the stock’s current price.

A number of other equities analysts have also recently commented on CL. UBS Group boosted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their price objective for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Bank of America boosted their target price on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Finally, JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Price Performance

CL stock traded up $0.73 during midday trading on Monday, reaching $96.34. 1,892,905 shares of the company’s stock traded hands, compared to its average volume of 4,338,212. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The company has a market cap of $79.04 billion, a price-to-earnings ratio of 30.46, a PEG ratio of 3.54 and a beta of 0.40. The company has a 50-day simple moving average of $103.15 and a two-hundred day simple moving average of $98.06. Colgate-Palmolive has a 1-year low of $72.36 and a 1-year high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The firm had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period last year, the company posted $0.77 EPS. On average, analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Insider Buying and Selling at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the completion of the sale, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 over the last three months. Corporate insiders own 0.34% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Hedge funds and other institutional investors have recently bought and sold shares of the company. Main Street Research LLC increased its position in shares of Colgate-Palmolive by 1.5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after acquiring an additional 100 shares during the last quarter. Advisor OS LLC grew its stake in shares of Colgate-Palmolive by 4.5% in the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after purchasing an additional 101 shares during the last quarter. BLB&B Advisors LLC raised its holdings in Colgate-Palmolive by 2.5% in the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock worth $421,000 after purchasing an additional 104 shares in the last quarter. ZWJ Investment Counsel Inc. raised its holdings in Colgate-Palmolive by 3.1% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock worth $349,000 after purchasing an additional 109 shares in the last quarter. Finally, Hexagon Capital Partners LLC boosted its position in shares of Colgate-Palmolive by 9.5% in the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after purchasing an additional 110 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.